Related Experiment Video
Updated: May 12, 2026
07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Hypoxia-inducible factor-1α as prognostic marker.
Amin Ben Lassoued1, Nathalie Beaufils, Jean-Philippe Dales
1Laboratoire de Biochimie et de Biologie moléculaire, Assistance Publique-Hôpitaux de Marseille (AP-HM), Hôpital Nord, Marseille, France. amin.benlassoued@ap-hm.fr
Expert Opinion on Medical Diagnostics
|March 28, 2013
Summary
Hypoxia-inducible factor-1α (HIF-1α) is a crucial cellular sensor regulating adaptive responses to low oxygen. Understanding HIF-1α biology is vital for developing new cancer diagnostics and targeted therapies.
Area of Science:
- Molecular Biology
- Cellular Physiology
- Cancer Biology
Background:
- Hypoxia-inducible factor-1α (HIF-1α) acts as a central cellular sensor for hypoxia.
- HIF-1α regulates critical physiological processes like metabolism, erythropoiesis, and angiogenesis.
- Dysregulation of HIF-1α is implicated in carcinogenesis, cancer progression, and metastasis.
Purpose of the Study:
- To review the regulatory mechanisms of HIF-1α.
- To elucidate the physiological and pathophysiological roles of HIF-1α.
- To discuss the diagnostic and prognostic potential of HIF-1α.
Main Methods:
- Literature review of HIF-1α biology.
- Analysis of physiological and pathophysiological effects.
- Evaluation of recent studies on HIF-1α significance.
Main Results:
- HIF-1α is a pleiotropic factor involved in numerous cellular adaptive responses.
- Its role extends from normal physiology to complex pathological conditions, particularly cancer.
- Recent research highlights its potential as a biomarker.
Conclusions:
- HIF-1α is a key regulator in both normal and disease states.
- Its significance in cancer diagnosis and prognosis is increasingly recognized.
- Further understanding of HIF-1α pathways may lead to novel therapeutic strategies.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:23Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...